Doctor examining a patient with a stethoscope

Our purpose is to reimagine medicine to improve and extend people's lives.

Scientist working in a lab

Our vision is to become the most valued and trusted medicines company in the world.

Scientist working on a computer

Our strategy is to deliver high-value medicines that alleviate society’s greatest disease burdens through technology leadership in R&D and novel access approaches.

Focus Areas

To support this strategy, we have clear focus areas and priorities to create value for our company, our shareholders and society.

Therapeutic Areas

Our focus is in 5 core therapeutic areas:
  • Cardiovascular
  • Immunology
  • Neuroscience
  • Solid Tumors
  • Hematology

These areas have significant disease burden.

Business people in a meeting room looking at a screen displaying a 3D heart


Technology Platforms

Our technology platform areas are:
  • Chemistry
  • Biotherapeutics
  • xRNA
  • Radioligand
  • Gene and cell therapy

We have the depth and scale to discover, develop and commercialize therapies.

CAR-T cells attacking cancerous B-cells


Strategic Priorities

These focus areas are supported by strategic priorities, which determine how we implement our strategy.

Growth icon

Deliver high-value medicines to accelerate growth.

Gear icon

Embed operational excellence to deliver returns.

Stakeholders hands icon

Strengthen our foundations by:

  • Unleashing the power of our people
  • Scaling data science and technology
  • Building trust with society